| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT02497157 |
| P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
| P17 | country | Japan | Q17 |
| P582 | end time | 2019-05-01 | |
| P4135 | maximum age | 70 | |
| P2899 | minimum age | 20 | |
| P1132 | number of participants | 45 | |
| P4844 | research intervention | fluorouracil | Q238512 |
| irinotecan | Q412197 | ||
| calcium oxalate | Q412399 | ||
| bevacizumab | Q413299 | ||
| leucovorin calcium | Q27077063 | ||
| P1813 | short name | BeTRI | |
| P580 | start time | 2015-05-21 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Phase II Trial of FOLFOXIRI + Bevacizumab in Patients With Untreated Metastatic Colorectal Cancer |